AOD 9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is Does AOD9604 peptide demonstrate effective fat loss in humans? Consensus Retatrutide & AOD9604: A Deep Dive into the "Triple Plus" Protocol We know that Retatrutide is the new heavy hitter on the block, but when you add AOD9604 to the mix, you aren't The Journey of AOD 9604: From Clinical Trials to Cosmetic Triumphs
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols